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Those are my principles. If you don’t like them I have 
others. 
Groucho Marx      
  
ABSTRACT 
Background: Gallstone disease is a major cause of morbidity and at least 10 000 cholecystectomies are performed 
annually in Sweden. At the time of surgery about 5-15% of the patients also have common bile duct stones (CBDS). 
Introduction of new techniques like Endoscopic Retrograde CholangioPancreatography (ERCP) and laparoscopy 
have changed the treatment for these patients.  
Aims: To analyze how CBDS has been treated in Sweden 1965-2009 and to calculate mortality connected to the 
different procedures, to assess the risk of malignancy after ERCP in benign disease and identify risk factors for death 
within 90 days. To evaluate the short term clinical outcome and identify risk-factors for failure in laparoscopic 
transcystic common bile duct exploration (LTCE). 
Methods: Data on all patients with an in-patient procedure code of common bile duct exploration or ERCP 1965-
2009 were collected from the Swedish Hospital Discharge Register and those with a diagnosis of malignancy in the 
bile ducts, liver or pancreas were excluded. The outcome death was identified by cross-linkage to the Registry of 
Causes of Death and readmission in the Swedish Hospital Discharge Register. For assessment of cancer risk a cohort 
study of all patients in Sweden having had an ERCP before the end of 2003 without a diagnosis of malignancy at the 
time of the procedure or within two years after it was performed. To calculate mortality and analyze risk-factors for 
death after ERCP a case-control study based on the population of Stockholm 1990-2003 was performed. Cases were 
defined as patients having died within 90 days of the procedure and controls were randomly chosen among those who 
did not die. Data were collected prospectively on patients having a cholecystectomy at S:t Göran’s Hospital 1994-
2002, in 155 patients a LTCE were attempted and the outcome analyzed. 
Results:  The Swedish Hospital Discharge Registry contained records of 126 885 procedures for treatment of 
common bile duct stones in 110 119 individuals, without a diagnosis of malignancy at the time of the procedure, 
during 1965-2009. The 90-day mortality was 0.24 % after open surgery, 0.90% after ERCP, 0.67% after combined 
procedures and 0% after laparoscopic surgery. After adjustment for confounding factors, mainly age and comorbidity, 
in the multivariate analyses there was no significant difference in mortality between open surgery and ERCP. The risk 
of malignancy in the bile ducts alone and in the bile ducts, liver and pancreas together was  significantly elevated in 
the cohort of individuals having had an ERCP before 2003,  irrespective of if an ES was performed or not. The risk of 
malignancy diminished with increasing follow-up time. Patients ever having had a cholecystectomy had a 
significantly lower risk of the studied malignancies. In Stockholm County during 1990-2003 the 90-day mortality 
after ERCP was 1.6%. Advanced age, severe comorbidity, high complexity of the procedure and the occurrence of a 
complication were associated to death within 90 days, whereas a previous cholecystectomy or the simultaneous 
performance of an endoscopic sphincterotomy reduced the risk. An attempt of transcystic CBD exploration with 
complete stone clearance in the 155 patients at S:t Göran’s Hospital could be fulfilled in 85 %. The median operating 
time was 184 minutes (range 89-384 minutes) and the median postoperative hospital stay was one day. There was a 
significant 3-fold increase in risk of failure of clearance of the bile ducts among patients with stones of >5 mm 
compared to patients with stones 5 mm. 
Conclusions: Common bile duct stones were mainly treated endoscopically.  ERCP and open surgery were 
associated with a similar mortality after adjustment for confounding factors. Laparoscopic treatment was chosen in 
younger and healthier patients, probably with a less severe disease, and no 90-day mortality was recorded. The risk of 
malignancy in the bile ducts, liver or pancreas was elevated after ERCP in benign disease. However, ES did not seem 
to affect this risk. Old age and comorbidity were the main risk factors for death after ERCP but a complex procedure 
or the occurrence of a complication also seemed to increase short term mortality. The performance of a 
sphincterotomy may decrease the risk of death, possibly by facilitating adequate drainage. Previous cholecystectomy 
may also decrease the risk of dying after ERCP. Laparoscopic transcystic exploration of the CBD had a high 
frequency of stone clearance and low morbidity in the present study. Moreover, large stones were a risk factor for 
failure in stone clearance. 
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1 INTRODUCTION 
 
Gallstone disease is a major cause of morbidity world-wide. About 10-15 % of 
Europeans have gallstones and though many of them are asymptomatic and need no 
treatment at least 10 000 cholecystectomies are performed annually in Sweden. About 
5-15 % of the patients also have stones in the common bile duct at the time of surgery. 
When open surgery was performed these stones were removed at the same time 
through a choledochotomy. Treatment of common bile duct stones has changed, first by 
the introduction of endoscopic retrograde cholangiography with endoscopic 
sphincterotomy in the 1970s and later by the revolution of laparoscopic cholecyst-
ectomy. The endoscopic treatment was initially used in patients who had had a previous 
cholecystectomy or when surgery was considered too risky. When laparoscopic 
cholecystectomy was introduced several alternative techniques were used to treat 
patients with simultaneous stones in the common bile duct: conversion to open surgery, 
combinations of laparoscopic and endoscopic methods in one or two stages and finally, 
laparoscopic treatment of the common bile duct stones as well, either by laparoscopic 
transcystic exploration or by a laparoscopic choledochotomy. Presently all techniques 
are being used and which one to choose is probably often decided by local tradition. 
 
1.1 HISTORY OF GALLSTONE DISEASE AND TREATMENT 
Concerning the liver and the biliary tract there are early records of observations by 
man. About 2000 B.C. the Babylonians described the gallbladder and the extrahepatic 
biliary tree in sacrificial animals and made a clay model of them, currently on display at 
the British Museum. The Babylonian and Assyrian priests examined organs to interpret 
omens and the model is believed to have been used to instruct their students [1]. 
The liver was believed to be the centre of the soul, which gives light to the extreme 
gravity of Prometheus’ fate, that was to have his liver plucked by vultures in eternity, a 
punishment for defying Zeus and bringing fire to mankind [2]. 
 
Biliary tract stone disease has tormented man since ages. The oldest gallstone known 
was found in Gotland, in the remnants of a tomb dating back to the Stone Age, 
approximately 4000 years old [3].  
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The mummy of a priestess of the 21st dynasty in ancient Egypt (about 1000 B.C.) was 
found with a preserved liver with a gallbladder containing 30 gallstones. The mummy 
was presented at the Royal College of Surgeons in London in 1909, but destroyed in 
the bombings during World War II, now only photographs remains [1, 4].  
 
Alexander the Great died at the age of 34. The cause of his death is believed to have 
been malaria or an overdose of Hellebore (Christmas rose) but the course of his disease 
was also compatible with perforation of the gallbladder or associated pancreatitis. After 
a party of excess alcohol intake and overeating he deceased after eleven days of fever 
and abdominal pain [1].  
 
The earliest description of biliary stones and colic is probably to be found in the works 
of Alexander of Tralles, a Greek physician of the fifth century, however neglected in 
favour of the theories of Galen, who thought that the yellow bile (one of the four body 
fluids in humoral pathology) was produced in the gallbladder and disorders of it was 
held responsible for diseases like cholera [1].  
 
In 1556 an autopsy was performed on Saint Ignatius of Loyola, the founder of the Jesuit 
Order, by Realdo Colombo, an anatomist from Padua. Numerous gallstones were found 
in the gallbladder and also a large stone impacted in the common bile duct which had 
eroded into the portal vein. This was one of the earliest descriptions of adverse effects 
of stones in the biliary tree but successful treatment lacked for a long time. The famous 
English anatomist Francois Glisson stated in 1678 that “only death was the solution for 
biliary colic” [4].   
 
Elective surgery of gallstone disease was first proposed by J L W Thudichum in 1859, 
a description of which was  published in the British Medical Journal the same year [5]. 
His method of choice was the forming of a biliary fistula by fixing the gallbladder in an 
abdominal wound and then removing gallstones after crushing them. J L W Thudichum 
didn’t use the method himself but it was adopted by several other surgeons, including 
Theodor Kocher [6, 7].  
 
The first cholecystectomy was performed in 1882 by Carl Langenbuch in Berlin. A 43-
year old man with recurrent attacks of biliary colic and obstructive jaundice was purged 
for five days prior to surgery. The operation was performed through a “macroinvasive” 
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incision, a “T” with one limb of 10-15 cm below the right costal margin and the other 
of the same length along the lateral margin of the rectus abdominis muscle. The cystic 
duct was ligated with silk and the gallbladder removed. The patient had a cigar the 
following morning and was strictly forbidden to leave his bed for twelve days. He 
survived and was discharged from hospital seven weeks later [8]. The new method was 
ignored and even received with contempt by Langenbuch’s contemporary colleagues 
and not adopted until the end of the century.  
 
The first common bile duct explorations were done in London in 1889 by Knowsley 
Thornton and in Basel in 1890 by Ludwig Courvoisier who introduced the use of a T-
tube for safer closure of the common bile duct [4, 9, 10]. However, surgery of the 
common bile duct remained to be a “risky business” illustrated by the fact that William 
Halsted, the famous American surgeon, watched his mother die of complications of 
common bile duct stones even though she had been operated on by her legendary son. 
Ironically he himself died of the same disease in 1922 in spite of the fact that his former 
students and colleagues at Johns Hopkins University in Baltimore performed three 
operations on him. The autopsy showed a large common bile duct stone, impacted in 
the papilla [4, 11].  
 
The surgeons blamed the gastroenterologists for referring the patients too late thereby 
causing an overrepresentation of hopeless cases and a high mortality. The mortality 
after surgery was indeed very high, in the first decades of the 20th century reports were 
published with a mortality of 8-9 % after cholecystectomy with exploration of the 
common bile duct and 6 % after simple cholecystectomies [3].  
 
In 1974 gastroenterologists from Japan and Germany described an endoscopic 
alternative to treat common bile duct stones by Endoscopic Retrograde 
Cholangiopancreatography (ERCP). The papilla of Vater where the common bile duct 
and the pancreatic duct enter the duodenum was localized, the common bile duct 
cannulated and if common bile duct stones were diagnosed they could be removed after 
the performance of an endoscopic sphinterotomy (ES) of the biliary sphincter of Oddi. 
The technique was recommended to be used in patients with stones impacted in the 
ampulla of Vater and used exclusively in patients who had had a prior cholecystectomy 
or in those considered unfit for surgery [12, 13]. 
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A major change in the treatment of gallstones occurred in the late 1980s when 
laparoscopic cholecystectomy was introduced. The French surgeon and gynaecologist 
Philippe Mouret performed a laparoscopic cholecystectomy in 1987 starting a 
revolution in surgery [14, 15]. The technique was not new, in fact a German surgeon, 
Eric Mühe, from Böblingen had performed a similar operation a few years earlier [16] 
and the Swedish physician Hans Christian Jakobaeus had described laparo- and 
thoracoscopy as early as 1912 [17]. It was however the invention of a video computer 
chip that allowed the image to be shown on a television screen that started the 
laparoscopic era [18]. 
 
1.2 ABOUT GALLSTONE DISEASE 
1.2.1 Prevalence  
                      The prevalence of gallstone disease varies around the world. Ultrasound studies reveal 
gallstone disease in about 10-15% of adult individuals in Western countries and in 3-
5% of African and Asian populations [19]. A very high prevalence is seen among adult 
Pima Indian women in south Arizona (73 %) [20] while in Sweden the frequency is 
estimated to be 11% in women [21]. It rises with age from 11% in 40 year old women, 
25% in 60 year women and in 77-78 year old women 51 % have gall stone disease or 
have had a cholecystectomy. Gallstone disease is not so common in Swedish men, it is 
found in 4%  of 40 year old men and 15 % in the 60 year old [22, 23]. The difference 
between men and women concerning prevalence of gallstone disease has been 
explained by Jorgensen to be related to estrogen therapy and child birth [24]. About 60-
80 % of gallstones are silent, giving no symptoms, and need no treatment [25]. With the 
high prevalence of gallstone disease the remaining symptomatic gallstones will raise a 
demand on national health care. In the Scandinavian countries the cholecystectomy rate 
annually is 6-12/10 000 inhabitants [26] and presently in Sweden 10 000-11 000 
cholecystectomies are performed every year [27].  
 
1.2.2 Pathogenesis 
Gallstones are divided into three major categories: Cholesterol, brown pigment and 
black pigment stones depending of their composition and pathogenesis. They can also 
be divided into two categories depending of their origin; the gallbladder or the 
intrahepatic bile ducts. 
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In Western countries about 75-80% of the stones are cholesterol-based [28] and female 
gender, fecundity and a family history of gallstone disease are strong risk factors as 
well as the metabolic syndrome for development of cholesterol gallstones [29]. Dietary 
constituents are more questionable, Cuevas et al stress the fact that high energy simple 
sugar and saturated fat favours cholesterol gallstone formation while fibres and alcohol 
consumption reduces the risk [30] but legume intake is also identified as a risk factor 
for gallstone formation [31].   
 
Cholesterol is made soluble in bile by micelle formation with bile salts and 
phospholipids and precipitation occurs when the bile is hypersaturated with cholesterol 
or hyposaturated with phospholipids. The supersaturated cholesterol nucleates into 
crystals and the crystals form into stones [29, 32] in the gallbladder [33] from where 
they can migrate through the cystic duct or through the wall of the gallbladder into the 
bile ducts [34]. Impaired gallbladder motility is a risk factor for gallstone formation 
though it may be a secondary effect of the biliary cholesterol supersaturation [35]. 
 
Pigment stones have an estimated prevalence rate of about 20-25% among patients 
undergoing cholecystectomy [36] and while black pigment stones form in the 
gallbladder and is associated with biliary hypersecretion of bilirubin or impairment of 
the enterohepatic recycling of bilirubin [37], brown pigment stones form in the 
intrahepatic bile ducts as a result of bacterial infection and biliary stasis [33]. Brown 
pigment stones are more common in Asia while in western countries cholesterol stones 
are predominant.  
 
1.2.3 Symptoms 
In many cases biliary stones are asymptomatic [25] and otherwise non-specific. 
Symptoms of gallbladder stones such as biliary colic are considered to be caused by the 
impaction of one or several stones in the gallbladder neck. The most common symptom 
is abdominal pain with radiation to the upper back with onset more than an hour after a 
meal. However, abdominal pain for other reasons is common in the population and 
biliary stones are often silent [38, 39]. Muhrbeck found abdominal symptoms to be as 
common in individuals with gallstones as in those without [40].   
 
In a Swedish study of asymptomatic patients with gallstones about 10% develop 
symptoms or complications that require treatment within five years [41] which is 
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compatible with the literature review made by Friedman [42] but higher incidences 
have also been reported [43].         
 
Food intolerance is commonly believed to be a symptom of gallstone disease and is 
typically described as a tendency of abdominal pain related to intake of fatty or fried 
food and fruit and vegetables with thin skins. Festi et al found abdominal pain related to 
intake of fatty food in a significantly larger extent in gallstone patients [44], in 
opposition to other studies [38, 45].  It has been argued that the food intolerance is not 
related to the gallstones themselves and could persist after surgery [46]. In summary, 
symptoms of uncomplicated biliary stones are often vague and hard to interpret. 
 
1.2.4 Radiology in Diagnosis of Gallstone Disease 
Since gallstone disease gives non-specific symptoms the establishment of a correct 
diagnosis could not have been easy before the introduction of radiological methods. In 
1890 plain x-ray was introduced and gallstones could be detected if they were calcified 
which occurs in only about 10-15%. In 1924 Evarts Graham and Warren Cole 
performed a cholecystography, the gallbladder was visualized after intravenous 
injection of tetrabromphenolphthalein and failure to obtain a shadow was interpreted as 
cholecystitis [47]. Several roentgenograms were taken during a period of 32 hours. 
Today the diagnosis of gallstone disease is quite easily made by ultrasound, introduced 
in the 1970s, no preparations other than six hours of fasting is needed and a correct 
diagnosis is set in >90% [48, 49] of gallbladder stones. 
 
1.2.5 Indications for Treatment in Gallstone Disease 
Gallbladder stones are asymptomatic in many cases and no treatment is necessary [50] 
[51], however some authors have recommended prophylactic surgery in children, due 
to the unknown natural course of gallstone disease among pediatric patients [52]. There 
have been suggestions that asymptomatic stones should be treated in diabetic patients, 
due to a higher incidence of infectious complications and that cholecystitis presents 
unexpectedly and proceeds quickly in diabetics [53], but that strategy is refrained from 
since later studies showed no benefit. Prophylactic treatment is no longer recommended 
[54, 55]. On the other hand, in symptomatic gallbladder stones treatment is 
recommended [56, 57], since the risk of development of a complication is higher.  The 
importance of a proper assessment before surgery was illustrated by Halldestam et al 
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who found that patients who had typical pain location and specific food intolerance had 
a lower risk of persistent abdominal pain after elective cholecystectomy [58]. 
 
1.2.6 Complications 
Simple gallstone disease could be complicated by cholecystitis, acute pancreatitis, 
gallstone ileus, gallbladder carcinoma and finally common bile duct stones the latter 
being the scope of this thesis. The risk of complications has been correlated to the 
patient’s age at the time of onset of biliary symptoms [59] and also to the severity of the 
symptoms [42, 60, 61], older age and more severe symptoms being risk factors for the 
occurrence of a complication. 
 
1.2.6.1 Acute Cholecystitis 
Acute cholecystitis is caused by an obstruction of the cystic duct by gallstones or 
sludge impacted in Hartman’s pouch, leading to an increased pressure in the 
gallbladder in presence of bile hypersaturated with cholesterol [62]. The distension 
enhances prostaglandin formation giving a vicious circle since the prostaglandins 
further activates the epithelial cells to secrete fluid [63], also explaining why 
prostaglandin inhibitors relieve pain [64]. The inflammation is often sterile and the 
bacterial growth demonstrated in 40-60% of cases is believed to be secondary [65, 66]. 
Acute cholecystitis is generally considered to be an indication for surgery, either in the 
acute stage or as a delayed procedure. In high-risk patients needing treatment a 
cholecystostomy could be performed as a temporary solution [67]. 
 
1.2.6.2 Gallstone Pancreatitis 
Biliary pancreatitis is the most frequent form of acute pancreatitis in western countries 
[68] and it occurs in about 3-8% of patients with symptomatic gallstones [69]. 
Microlithiasis has been detected in a substantial part of patients previously classified as 
having idiopathic pancreatitis [70, 71]. The pathogenesis of biliary pancreatitis may be 
multifactorial but two mechanisms could be of importance: reflux of bile into the 
pancreatic duct, as proposed by Claude Bernard already in 1856 and transient 
ampullary obstruction, caused by a stone or sludge passing through the ampulla of 
Vater into the duodenum or impacted in the ampulla [72]. The obstruction gives a raise 
of the pressure in the pancreatic duct and thereby an activation of digestive enzymes 
[73, 74].  
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In Denmark a 30-day  mortality of 5% and one-year mortality of 11% has been reported 
[75] and in a literary review a decreasing mortality (<10%) is reported in later studies 
compared to 15-21% in the earlier from 1960-1985 [76]. Mortality rises with age and 
by the severity of the pancreatitis. Many scoring systems have been used for predicting 
the subsequent occurrence of multiple organ failure causing death since the severity is 
not always clinically apparent at admission [77-79].  
 
In biliary pancreatitis indication for definite treatment of gallstones is very strong since 
recurrence rate otherwise is as high as 25-61% [80, 81]. However, the timing of the 
procedure has been a topic of debate. During the days of open surgery Kelly and 
Wagner did a prospective study of mortality and morbidity in early and delayed surgery 
and found it to be much higher in early surgery. On the other hand Burch et al reported 
similar mortality but a higher incidence of recurrent biliary attacks in the delayed group 
[82]. More recent reports during the laparoscopic era have shown an advantage of early 
surgery. In a Swiss study of 112 patients  no difference in mortality or morbidity could 
be shown, but early cholecystectomy gave a lower risk of new biliary attacks [83]. Uhl 
et al recommend early (within 7 days) surgery in cases of mild pancreatitis, while in 
severe cases surgery should be postponed at least three weeks, due to increased risk of 
infection [84]. In the IAP guidelines for surgical management of acute pancreatitis 
three grade B guidelines concerning surgery to prevent future attacks of biliary 
pancreatitis are stated: cholecystectomy should be performed to prevent further attacks, 
in mild biliary pancreatitis surgery should be performed as soon as the patients have 
recovered, ideally during the same admission, and in severe gallstone-pancreatitis 
cholecystectomy should be delayed until the patient has recovered with sufficient 
resolution of the inflammatory response [85]. The indication for early ERCP in 
gallstone pancreatitis has also been much debated. Fan et al reported beneficial effects 
of ERCP performed within 24 hours of admission in terms of lower incidence of biliary 
sepsis [86] and Neoptolemos found benefits concerning morbidity but not mortality, 
[87] while Petrov in a metaanalysis found no reduction of mortality or complications of 
early ERCP in patients with predicted mild or severe gallstone pancreatitis but without 
cholangitis [88]. 
  
1.2.6.3 Gallstone Ileus 
Gallstone ileus is a rare complication of gallstone disease. It arises mostly in the elderly 
and accounts for about 1-4% of all cases of mechanical bowel obstruction [89]. It 
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occurs when a gallstone erodes the gallbladder wall into the intestinal lumen and gets 
impacted in the valvula of Bauhini although impaction in other locations of the 
gastrointestinal tract has been described [90, 91]. The management is associated with 
high morbidity and also mortality and consists of enterotomy with retrieval of the 
gallstone. A laparoscopic approach has also been described [92]. Whether a biliary 
procedure should be added and the timing of such a procedure remains a controversy. 
The literature consists mainly of single centre experiences of small numbers of patients 
collected over many years and in a recent review Ravikumar and Williams argued that 
future case series would hardly help decision making [93]. 
 
1.2.6.4 Gallbladder Carcinoma 
There is a strong association between gallstone disease and gallbladder cancer since 
gallstones are present in a vast majority of gallbladder cancer patients [94, 95] and the 
size of gallstones is a major risk factor, the bigger the stones the bigger the risk of 
development of a carcinoma [96]. However, the causal relationship between stones and 
development of carcinoma remains unclear [97].  
 
1.3 COMMON BILE DUCT STONES 
1.3.1 Prevalence 
About 5-15 % of patients with symptomatic gallstones have common bile duct stones 
(CBDS) at the time of surgery [43, 98, 99], the portion grows with increasing age and 
duration of symptoms. CBDS that appear after common bile duct surgery or endoscopy 
are defined as retained if they are diagnosed less than six months postoperatively, 
otherwise as recurrent. Retained stones, mostly due to incomplete clearance, are 
reported in a frequency of 4-10% after both surgery and ERCP [100-102]. The rate of 
recurrence after ERCP is estimated to be 10-20% and as risk-factors for recurrence a 
gall-bladder left in situ (if it contains gallstones), a bile duct with a diameter > 15mm 
and the existence of a periampullary diverticula have been identified [103-105] . The 
risk of recurrence after ERCP is about the same as after open surgery [100] but it may 
be lower after laparoscopic common bile duct surgery [106, 107]. 
 
1.3.2 Pathogenesis 
Most common bile duct stones form in the gallbladder and migrate through the cystic 
duct to the common bile duct and are composed as gallbladder stones, i.e. in Europe 
predominately of cholesterol, but they may also form primarily in the common bile 
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duct. Brown pigment stones, however uncommon in the Western world, form in the 
intrahepatic bile ducts in patients with infections and obstruction.  
 
Mirizzi syndrome was originally described in 1948 as jaundice caused by a gallstone 
impacted in the gallbladder neck compressing the bile duct and thereby causing 
obstruction. It has later been classified by Csendes et al into four categories. In type I 
obstruction is caused by the external compression originally described, in type II a 
cholecystobiliary fistula is present with destruction of less than one-third of the 
diameter of the bile duct. In type III the fistula involves up to two thirds of the duct 
diameter while in type IV there is a complete destruction of the bile duct [108]. Mirizzi 
syndrome is known to be difficult to diagnose. In a British retrospective study of 33 
patients it was found that the diagnosis was most easily set with MRCP [109]. 
 
1.3.3 Symptoms 
The natural history of common bile duct stones is unpredictable, varying from no 
symptoms at all to life-threatening conditions. Rosseland found asymptomatic CBDS in 
up to 10% of  patients scheduled for laparoscopic cholecystectomy [110], making the 
prevalence of common bile duct stones at the time of cholecystectomy hard to predict 
in spite of the use of scoring systems [111-113]. CBDS may also pass spontaneously 
into the duodenum without causing symptoms or reside in the bile duct for a long time 
and still be asymptomatic, in a literature review Metcalfe et al found that to be the case 
in 85% of patients with stones discovered unexpectedly during surgery [114].  
The most common symptom is biliary colic while jaundice, cholangitis and pancreatitis 
would rather count as complications of common bile duct stones.  
 
When a bile duct stone gets impacted in the papilla it will cause obstructive jaundice, 
often fluctuating, when jaundice clears the stone may have passed into the duodenum 
but it may also have floated up in the bile duct.  
 
Cholangitis is a result of an infection complicating obstructive jaundice and has been 
reported with a mortality of 13-88% if left untreated [115]. The classical symptoms of 
Charcots triad (jaundice, fever and pain) is encountered in about 75% of the patients 
but in some this life-threatening condition is presented with vague symptoms [116]. 
Stones passing the papilla may also induce a pancreatitis by obstructing the pancreatic 
duct (se above).  
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In longstanding obstruction secondary biliary cirrhosis and portal hypertension may 
develop [102]. 
 
Patients with symptomatic common bile duct stones could have a higher risk of 
developing a complication, studies have shown a risk of 25-50% of jaundice, 
cholangitis or pancreatitis if the stones were left untreated [116] and in a Dutch study of 
175 patients with complicated gallstone disease half of the patients had had “warning” 
colic attacks five months before the complication occurred [116, 117]. 
  
1.3.4 Radiology in Diagnosis of Common Bile Duct Stones 
Ultrasound is frequently used in the diagnosis of gallbladder stones but is less 
trustworthy in terms of sensitivity in diagnosing common bile duct stones, especially if 
they don’t cause dilatation of the bile duct [116] which is the case in about half of the 
patients [118]. The sensitivity for detection of intraductal stones is 10-63% [119-121] 
but since the specificity is high ultrasound remains an important tool and is often used 
as primary imaging modality. 
 
At computed tomography (CT) biliary stones are heterogenic in appearance from 
heavily calcified too less radiopaque than bile when containing mainly cholesterol. 
They can also have gas attenuation due to nodules of nitrogen gas [118].  The 
sensitivity for detection is reported to be 69-88% and the specificity 83-97% [122-124]. 
Contrast material excreted in the bile can be injected intravenously for better sensitivity 
but the use is not wide-spread, perhaps because the excretion is variable and reduced 
when serum bilirubin is high. It is also believed to cause more severe allergic reactions 
than conventional intravenous contrast material [118] and no water-soluble iodine-
based contrast material with affinity to the liver is available for use in Sweden [125].  
 
Magnetic Resonance (MR) imaging is generally better than CT in diagnosing common 
bile duct stones [118] and with special techniques it has the advantage of permitting 
imaging of the whole biliary tract within one breath-hold [126]. T2 weighted MR 
cholangiography is highly sensitive and specific in the detection of CBDS while T1 
weighted images give a more variable appearance [118]. Sensitivity is reported to be 
88-100% and specificity 72-97% [127-129]. However, when the stones are small (< 3 
mm) sensitivity of detection by MR is low, maybe as low as 50% [130]. 
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Endoscopic ultrasound (EUS), where an ultrasonic probe is placed in the duodenum 
under endoscopic guidance, gives a detailed imaging especially of the distal common 
bile duct [131]. EUS has been used the last twenty years for diagnosing CBDS and in 
two meta-analyses the pooled sensitivity and specificity were 89-94% and 94-95% 
respectively [132, 133], comparable to the sensitivity and specificity of MR.  EUS is 
useful for diagnosing microlithiasis (stones < 3 mm) in pancreatitis and in “idiopathic 
pancreatitis” the cause can be identified in up to two-thirds of the patients [70] where 
other modalities have failed but otherwise the choice between MR and EUS is decided 
by local availability [102]. 
 
The evolvement of new less invasive modalities has gradually replaced ERCP as a 
diagnostic tool and it is nowadays used mainly as a therapeutic procedure [102]. 
Routine use of preoperative mapping of the bile ducts, such as intravenous 
cholangiography, MRCP or ERCP, to detect asymptomatic common bile duct stones 
and to reduce the risk of a bile duct injury by identifying anatomic anomalies, has been 
a topic of much debate [134]. Scoring systems containing a history of colic pain and/or 
jaundice, dyspepsia, cholecystitis, ultrasound describing number and size of stones in 
the gallbladder and the level of transaminases and/or alkaline phosphatase have been 
used to try to predict the existence of silent common bile duct stones prior to 
laparoscopic cholecystectomy thereby reducing the need of preoperative radiology 
[111, 112]. In patients with no history of jaundice or pancreatitis, normal liver function 
tests and a normal sized common bile duct (≤ 5 mm) Majeed et al reports a 6% risk of 
common bile duct stone [135]. Preoperative evaluation of the bile ducts is now much 
abandoned and in a Swedish study Järhult found it unnecessary since it had no impact 
on preventing bile duct injury or on the frequency of retained common bile duct stones 
[136].  
 
1.3.5 Indications for Treatment of Common Bile Duct Stones 
Ammori et al has suggested a policy of leaving small stones found unexpectedly in bile 
ducts of normal width at surgery and wait and see if symptoms occur before removing 
them [137], on the other hand Collins found no correlation between the number or size 
of silent stones or size of ducts and spontaneous passage [138]. However, it is generally 
agreed that all symptomatic bile duct stones should be removed [102, 111, 139].  
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Obstructive jaundice should be treated as an emergency due to potentially dangerous 
complications such as cholangitis, renal failure, cardiovascular dysfunction or 
coagulopathy [52, 102].  
 
1.4 TREATMENT 
Several attempts have been made to dissolve gallstones. In traditional Chinese medicine 
different herbs have been used and in Europe artichoke and hawthorn in wine were 
believed to have a dissolving effect. Aeter is also known to be able to dissolve 
gallstones and was used for many years before the era of surgery. It was probably one 
of the ingredients in “ Liquor anodynus mineralis Hoffmanni” [140, 141] used from the 
18th century in many conditions like colic and hysteria [142].  
 
Gallstones consist mainly of cholesterol in individuals of industrialised countries and 
are thereby susceptible to dissolution by bile acids, first described in 1937. A high 
success rate (80 to 90% in one year) has been reported in small calculi, but the 
recurrence rate is high [143]. Extracorporeal shock-wave lithotripsy (ESWL) has been 
used to disintegrate gallstones but it also has the disadvantage of a high recurrence rate 
[144] to some extent prevented by post- ESWL medication with bile acids. However 
Nicholl et all found that ESWL did not relieve symptoms and that it was not cost-
effective [145] and surgery was recommended as first line treatment of symptomatic 
gallstones. ESWL has also been used to fragment big common bile duct stones [146] 
but a randomized study of 60 patients with difficult common bile duct stones by 
Neuhaus et al showed intracorporal laser lithotripsy to be more efficient in clearing the 
bile ducts [147]. ESWL is still recommended as treatment for intrahepatic stones [148]. 
 
1.4.1 Surgery 
Cholecystectomy was first performed in 1882 and exploration of the common bile duct 
in 1889, initially and in the first decades of the last century with high mortality and 
morbidity, however with growing experience and the introduction of antibiotics in the 
1940s the mortality and morbidity decreased  [3, 85, 87, 149, 150]. In the 1970s small-
incision cholecystectomy was introduced and morbidity and complications seemed to 
decline [151]. Laparoscopic cholecystectomy was introduced in 1987 and became 
quickly the method of choice even though scientific evidence of its superiority were 
lacking [152]. A recent Cochrane report concluded a low mortality (< 0.09%) 
regardless of the method of access to the abdominal cavity chosen, no difference in 
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complications or risk of bile duct injury, but a shorter hospital stay and sick-leave for 
both mini-invasive procedures. Small-incision cholecystectomy had a shorter operating 
time and a lower cost than laparoscopic cholecystectomy [153] but the latter is by far 
the predominant procedure. In recent years new techniques have been introduced, 
single incision laparoscopic surgery (SILS) and natural orifice transluminal endoscopic 
surgery (NOTES), to reduce the number of incisions and thereby morbidity [154-156]. 
These methods need to be evaluated. 
 
The most feared complication of surgery is a bile duct injury, a lesion that has been 
reported to be more common in laparoscopic surgery, especially when the technique 
was introduced [157, 158]. The risk was increased in hospitals doing less than 100 
procedures yearly [159], to some extent similar to the findings of Andrén-Sandberg et 
al during the era of open surgery, that most bile duct injuries are caused by surgeons 
under training [160]. The increase has been explained to be a result of the learning 
curve but Waage et al found that not to be the case [161].  
 
Whatever access is chosen to the abdominal cavity the rest of procedure is more or less 
the same. The gallbladder in dissected either from above (fundus-first), a technique 
often used in open surgery and also recommended to be used in laparoscopic surgery 
[162] , though Dolan et al point out that using fundus-first technique could lead to a 
higher incidence of retained common bile duct stones[163], or from below. The critical 
point is the dissection of the triangle of Calot and the correct identification of the ducts, 
in laparoscopic cholecystectomy made easier by lateral traction of  the infundibulum of 
the gallbladder [164] and unintentional thermal damage could be avoided by careful 
use of electro-cautery in this area [165].  
 
The use of intraoperative cholangiography (IOC) was introduced by PL Mirizzi in 1931 
[166] and in Sweden by Hulten in Uppsala in 1937 [167] and since then there has been 
a debate of whether a routine use of peroperative cholangiography should be 
recommended or not [161, 168-170]. The main advantage would be that it would lower 
the risk of serious bile duct injuries [158, 161] while other studies find no such 
correlation [171, 172]. The main disadvantage would be that it is time-consuming and 
sometimes difficult to perform [173, 174]. It is however accepted that it should be done 
prior to an exploration of the bile ducts, thereby reducing the number of unnecessary 
explorations [170, 175]. 
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During the era of open cholecystectomy surgical removal of CBDS found under 
operation was considered gold standard and in a randomized trial between surgery 
alone and preoperative ERCP followed by biliary surgery Neoptolemos et al found no 
advantage of the two-stage procedure [176]. The introduction of laparoscopic surgery 
caused a change of therapeutic strategy since, at least in the beginning, no method of 
treating CBDS laparoscopically existed, instead a variety of options developed. The 
laparoscopic cholecystectomy could be converted to open surgery when CBDS were 
revealed or laparoscopic cholecystectomy could be combined with ERCP and ES either 
as a one-stage procedure or as a two-stage one where the endoscopy could be 
performed either before or after surgery. Laparoscopic techniques of common bile duct 
exploration have later evolved and CBDS can be removed either by a transcystic 
approach or by a choledochotomy (see below). 
 
1.4.2 ERCP 
When ERCP with endoscopic sphincterotomy (ES) was introduced in the 1970s [12, 
13] as treatment of common bile duct stones (CBDS) it was reserved for patients who 
had had a previous cholecystectomy or were considered unfit for surgery. After the 
introduction of laparoscopic cholecystectomy treatment of CBDS by ERCP and ES of 
the biliary sphincter of Oddi has become a routine procedure world-wide [102] even in 
young patients without previous cholecystectomy, a fact that could be alarming, since 
ERCP is known to cause complications in a substantial extent. Short-term 
consequences as perforation of the bowel, hemorrhage, cholangitis and pancreatitis are 
reported in 3-23% of cases with a mortality of 0-6% [177-180]. Late complications 
include cholangitis and stone recurrence reported in 10-15% of cases [179-181]. The 
splitting of the sphincter of Oddi has been reported to increase the risk of 
cholangiocarcinoma in the long run, thought to be an effect of long-standing bacterial 
overgrowth in the bile ducts due to an ascendant infection from the duodenum [181].  
In patients scheduled for laparoscopic cholecystectomy a policy of performing 
preoperative ERCP will result in a number of unnecessary potentially dangerous 
procedures [182, 183] since only 27-54% of the patients believed to have CBDS 
according to screening tests actually have so [184]. If on the other hand a postoperative 
ERCP is chosen a problem could be that the ERCP will sometimes fail, the papilla 
might be impossible to cannulate or clearance of the bile ducts may be difficult, Rhodes 
et al found a 93% clearance of the bile ducts when using postoperative ERCP [185]. 
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Randomized trials have however found that a  two-stage procedure has the same 
efficacy in treating CBDS compared to a single-stage one but implies a longer hospital 
stay and higher costs [185-187].  
 
During laparoscopic cholecystectomy insertion of a soft-tipped guide-wire through the 
cystic duct and sphincter of Oddi out in the duodenum could facilitate cannulation 
[187-189]. A single-stage rendez-vous procedure has been described by Enochsson et 
al, if the intraoperative cholangiography showed CBDS the guide-wire was introduced 
to duodenum through the IOC catheter by the surgeon while waiting for the endoscopy 
team to arrive. The endoscopist caught the guide-wire with a polypectomy snare and 
after pulling it through the working channel of the endoscope a sphincterotomy could 
be introduced. After ES the stones could be removed using a balloon or a basket and 
after the endoscopic intervention the surgeon could complete the laparoscopic 
cholecystectomy [188]. With this rendez-vous technique  Rabago et al found morbidity 
as well as post-procedure pancreatitis to be reduced, probably because injection of 
contrast material in the pancreatic duct could be avoided [187]. If intraoperative ERCP 
for some reason is refrained from, the guide-wire can be left in place after completed 
surgery an used to facilitate postoperative cannulation as a two-stage procedure [190]. 
ERCP and ES are still, as in the beginning, used also in patients who have had a prior 
cholecystectomy and as only treatment in biliary stone disease in elderly with a severe 
comorbidity. However, a recent Cochrane report concluded that there was a higher 
mortality if cholecystectomy was deferred from after ERCP and endoscopic clearance 
of common bile duct stones [191] in contrast to what earlier was recommended [192-
194]. 
 
1.4.3 Laparoscopic Exploration of the Common Bile Duct  
Laparoscopic exploration of the common bile duct could be done either by a transcystic 
approach or by a choledochotomy [195-197]. In the transcystic technique a guide-wire 
is placed through the cystic duct into the CBD. After balloon-dilatation of the cystic 
duct a thin choledochoscope is placed over the guide-wire and the stones are retrieved 
one by one. Good results have been published with a clearance of 85% or more [198, 
199] but the technique has limitations, big stones are not possible to pull through the 
cystic duct, intrahepatic stones may be impossible to reach and when there are 
numerous stones in the biliary tract the technique can be time-consuming. 
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 The laparoscopic choledochotomy has no limitations in size of stones [195, 200] but 
carries a higher morbidity that could be due to the use of a T-tube when closing the 
incision in the common bile duct [201]. Alternative techniques have been described, the 
common bile duct could be closed either by a direct suture  or over a stent instead of T-
drain [202]. In a Cochrane review dated 2007 Gurusamy and Samray found no 
evidence of benefit of the use of a T-tube or not [203] but in 2008 Leida et al published 
a randomized study of 80 patients and found a primary closure of the choledochotomy 
to be superior to the use of a T-tube by a shorter hospital stay, lower costs and less 
postoperative and biliary complications [201]. 
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2 AIMS 
 
Paper I aimed to analyze how CBDS has been treated in Sweden 1965-2009 and to 
calculate mortality and morbidity related to the different procedures. 
 
Paper II aimed to evaluate the relationship between ES for benign disease and 
subsequent development of malignancy in the biliary tract. A secondary aim was to 
study the relation between severe CBDS exposure and malignancy in the biliary tract.  
 
Paper III aimed to identify risk factors for mortality within 90 days of the procedure in 
patients who have had ERCP in non-malignant disease. The main hypothesis was that a 
potentially dangerous procedure like ES would be one such risk factor. 
 
Paper IV aimed to evaluate the short term clinical outcome, especially the stone 
clearance rate, of LTCE as well as to examine potential risk factors for failure in stone 
clearance in the use of this technique. 
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3 MATERIAL AND METHODS 
 
3.1 PAPER I, II AND III 
We used data from the Swedish Hospital Discharge registry (“slutenvårdsregistret”), 
where the Swedish National Board of Health and Welfare has been collecting data on 
individual hospital discharges since 1965. The coverage of the Hospital Discharge 
Register was 60% in 1969, 85% in 1983, and included all Swedish hospitals from 1987 
and thereafter [204]. By cross-linkage to the Swedish National Cancer Registry 
(“cancerregistret”) we identified individuals with a diagnosis of malignancy in the bile 
ducts, liver or pancreas. Cross-linkage to the registry of Causes of Death was 
performed to ascertain death as an outcome or censoring in the event of death and 
Domestic and International Relocations for censoring in the event of emigration of a 
cohort member. The Swedish National Cancer Registry is 98% complete [205] and the 
registry of Causes of Death (“dödsorsaksregistret”) is also essentially complete [206, 
207]. A detailed description of the methods used in these studies has been described 
elsewhere [208].  
 
3.2 PAPER I 
 
3.2.1 Study Base 
Using the national registration numbers we identified all individuals who had had at 
least one in-hospital episode with a discharge procedure code of open or laparoscopic 
exploration of the common bile duct, ERCP or ES (JKB00, JKB01, JKB11, JKB20, 
JKB21, JKE00, JKE02, JKE12, JKE15, JKE18, JKE25, UJK02, UJK05, UJK12, 
UJK15, 5300, 5302, 5304, 5351, 5352, 5356, 5357, 5388, 5394 and 9014 [209, 210]) 
during the years 1965-2009. This total cohort was divided into four sub-groups in the 
further analyses, open surgery (JKB00, JKB20, 5300, 5302, 5351 and 5352), ERCP 
(JKE02, JKE12, JKE15, JKE18, JKE25, JKE96, JKW96, UJK02, UJK05, 5388, 5394 
and 9014), laparoscopic common bile duct exploration (JKB01, JKB11, JKB21) and 
finally surgery combined with ERCP (any ERCP-code and any code for open or 
laparoscopic common bile duct exploration during the same hospital stay).  
 
The outcome death was identified by cross-linkage to the Causes of Death Registry. All 
individuals with discharge code or a code in the Swedish National Cancer Registry of 
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malignancy in the bile ducts, liver and pancreas (ICD 7 155-157 or corresponding 
codes in the later classification) within 90 days of the procedure were excluded. 
 
3.2.2 Registry Data 
From the Swedish Hospital Discharge registry we collected information on the age, 
sex, time-period, co-morbidity, complications and length of hospital stay, readmissions 
and redo procedures of the cohort members. 
.  
3.2.3 Statistical Analyses 
Survival among patients who have undergone treatment of common bile duct stones by 
open surgery, ERCP, laparoscopic exploration or combination of endoscopic and 
surgical methods was assessed by the Kaplan-Meier method.  
Cox proportional Hazard ratios (HR) and their 95% confidence intervals (CI) were used 
for univariate and multivariate assessment of the association between potential risk 
factors and the hazard of death within 90 days of the procedure. The potential risk 
factors used in the regression modeling were categorized in order to facilitate the 
analyses. Potential confounding effects were tested by introducing the variables under 
study stepwise into the multivariate regression model, and the risk factors were also 
tested for possible interactions. Statistical analyses were performed using SPSS version 
15.0 for Windows (SPSS, Inc., Chicago, IL). The level of statistical significance was 
specified to be 0.05.  
 
3.3 PAPER II 
 
3.3.1 Study Base 
From 1965 to 2003, we identified all individuals with at least one in-hospital episode 
with a discharge procedure code for ERCP or endoscopic sphincterotomy (Swedish 
Classification of Operations and Major Procedures, codes 9014, UJK02, UJK05, 
UJK12, UJK15 for ERCP or 5388, 5394, JKE 02, JKE 12, JKE 15, JKE 18, JKE 25, 
JKE 98 for ES or procedures for which ES normally is a prerequisite). This total ERCP 
cohort was in the further analyses divided into two subgroups: 1. Patients having at 
least one procedure code registration for ES or any other endoscopic biliary procedures 
for which an ES normally is a prerequisite (Swedish Classification of Operations and 
Major Procedures, codes 5388, 5394, JKE 02, JKE 12, JKE 15, JKE 18, JKE 25, JKE 
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98). 2. Patients in the cohort without any procedure code registration for ES or any 
other endoscopic biliary procedure implying ES. 
 
Those patients who had a diagnosis of malignant or benign tumour in the bile ducts, 
liver or pancreas at the time of the procedure or within two years after it were excluded 
from further analyses to avoid bias, since the registered ERCP in these cases may have 
been performed because of the tumour or due to symptoms caused by a tumour that 
was still undiagnosed. Considering the poor prognosis of malignancies in the biliary 
tract, liver and pancreas it is highly unlikely that a tumour causing symptoms would be 
diagnosed more than two years later. The cohort was then followed from entry until 
diagnosis of an outcome malignancy (primary malignant tumours in the liver, bile ducts 
including ampullary region and pancreas, but excluding gallbladder malignancy, ICD7 
codes: 155 and 157, but excluding 1551), death, emigration or end of follow-up 
(December 31st 2003), whichever occurred first.  
 
3.3.2 Statistical Analyses 
Several patients had ERCP or ES procedures registered at more than one point in time. 
As index procedure for cancer relative risk analyses were, first of all, every first time 
procedure for every patient. If the first time procedure included or implied ES the 
patient’s person-time was only included in the ES subgroup. If, on the contrary, a 
patient’s first time procedure was non-ES or ES-implying, and followed by a 
subsequent procedure including a code for, or implying, ES, this patient had two index 
procedures. One without ES, with person-time counted in the non-ES subgroup from 
two years after this procedure until the subsequent, second index procedure ES, after 
which person-time was counted in the ES subgroup from two years after that procedure 
and on.   
 
The standardized incidence ratio (SIR), the ratio of the observed to the expected 
number of malignancies, was used to calculate relative risk. The expected number of 
cancers occurring in the entire Swedish population was calculated by multiplying the 
observed person-time by age- (in 5-year groups), sex- and year of entry-specific cancer 
incidence rates. The standardized incidence ratios are inherently adjusted for 
confounding by age at follow-up, sex and year of entry. The 95% confidence intervals 
(CI) of standardized incidence ratios were calculated assuming that the observed 
numbers followed a Poisson distribution [211]. 
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To assess the general risk of malignancy in the cohort the SIR for all malignancies 
(ICD 7: 140 – 209) was performed. Moreover, the SIR for lung malignancy (ICD 7: 
162 – 163) was calculated as an indirect estimate of tobacco smoking exposure in the 
cohort, since smoking may be a relevant confounder, especially concerning pancreatic 
cancer risk analyses.     
 
3.4 PAPER III 
 
3.4.1 Study Base 
In the cohort used in paper II we identified all individuals of the population in 
Stockholm County with one or more in-patient episodes with a discharge code of any 
ERCP-procedure but without a diagnosis of malignancy at the time of the procedure 
from a Stockholm County hospital during 1990-2003. 
 
3.4.1.1 Case Identification 
Cases were defined as individuals in the study base who had died within 90 days of the 
procedure. For those registered as having undergone several procedures, the last one 
counted as index procedure. Of the 323 patients initially identified 90 were eligible to 
study. 
 
3.4.1.2 Selection of Controls 
The controls were randomly chosen from the study base among individuals not 
identified as cases and, as in the cases, when several procedures were registered, the 
last one counted as index procedure. Written informed consent was obtained from the 
control subjects who were still alive. 
 
3.4.2 Exposures 
The exposures studied were age, sex, hospital volume, time-period, co-morbidity, 
previous cholecystectomy, indication for the procedure, complexity of the procedure, 
pancreatic duct contrast injection, ES and finally the occurrence of complications. For 
age, sex, hospital volume, time-period, co-morbidity and previous cholecystectomy, 
registry data were used. Concerning indication for the procedure, complexity of the 
procedure, pancreatic duct contrast injection, ES and complications, data were collected 
by reviewing the medical records. The part of the medical record concerning the ERCP 
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procedure, including indications and complications, was coded with a number for each 
study subject and reviewed blinded for case or control status. 
 
3.4.3 Statistical Analyses 
Means and frequencies of exposures were calculated according to the outcome variable 
death or not. Data were presented as means ± standard deviations for continuous 
variables and proportions for dichotomized variables. Significant differences between 
groups were determined using Student’s t-test for comparisons of means and Chi-
square test for comparisons of proportions. 
 
Odds ratios (OR) and their 95% confidence intervals (CI), derived from unconditional 
logistic regression, were used for univariate and multivariate assessment of the 
association between potential risk factors and the outcome death within 90 days of the 
procedure. The potential risk factors used in the logistic regression modeling were 
categorized in order to facilitate the analyses. Potential confounding effects were tested 
by introducing the variables under study stepwise into the multiple logistic regression 
model, and the exposures shown to be significant in the univariate analysis were tested 
for possible statistical interactions. Statistical analyses were performed using SPSS 
version 15.0 for Windows (SPSS, Inc., Chicago, IL). The level of statistical 
significance was specified to be 0.05 and the fit of the model was estimated by the 
Hosmer and Lemeshow goodness-of-fit test [212].  
 
3.5 PAPER IV 
 
3.5.1 Study Base 
Laparoscopic transcystic common bile duct exploration (LTCE) was attempted in 155 
patients at S: t Göran’s Hospital during the years 1994-2002. Data on all patients 
having cholecystectomy was collected prospectively and registered in a database. 
During the time period a total of 3106 patients underwent cholecystectomy.  In 273 
patients the intraoperative cholangiogram suggested CBD stones and in 118 of them the 
surgeon chose other methods of stone clearance (conversion to open surgery, ERCP or 
laparoscopic choledochotomy). The 155 patients in whom LTCE was attempted were 
included in this study. The patients were followed up six week postoperatively 
including analysis of liver enzymes. If the tests were normal and the patient was well, 
no further follow-up was done.  
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3.5.2 Statistical Analyses 
All LTCE procedures registered were classified as either successful or failed with 
regard to stone clearance. Stone clearance was considered successful if a second 
intraoperative or postoperative cholangiogram after the attempted clearance showed no 
stones. 
 
The success rate was then analyzed with regard to age, sex, procedure priority, common 
bile duct diameter, number of stones, stone size, intrahepatic stones and length of 
hospital stay. In significance testing Fischer’s exact test was used for dicotomized 
discrete variables and the nonparametric Wilcoxon method for comparisons between 
means. 
 
Odds ratios (OR) and their 95% confidence intervals (CI), derived from unconditional 
logistic regression were used for  univariate and multivariate assessment of the 
association between studied potential risk factors and the risk of failure in stone 
clearance. Linear trends of the associations were tested by treating categorical variables 
as continuous in the logistic regression model. Potential confounding effects were 
tested by introducing the variables under study one by one into the model. 
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4 RESULTS 
 
4.1 PAPER I 
During the period 1965-2009 a total of 126 885 procedures of open or laparoscopic 
common bile duct exploration or ERCP were performed in 110 119 patients without a 
diagnosis of malignancy in the bile ducts, liver or pancreas at the time of the procedure 
or within 90 days after it. The distribution of the different procedures by five-year terms 
is shown in Figure 1. Endoscopic procedures have gradually replaced open surgery as 
treatment for common bile duct stones, only to a small extent challenged by 
laparoscopic methods.  
Figure 1. Treatment of Common Bile Duct Stones in Sweden 1965-2009.  
 
 
2005- 
2009 
2000- 
2004 
1995- 
1999 
1990-
1994 
1985-
1989 
1980-
1984 
1975-
1979 
1970-
1974 
1965-
1969 
Count 
20 000 
15 000 
10 000 
5 000 
0 
 
 
 
 
 
Open surgery 
ERCP 
Laparoscopic surgery 
Surgery and ERCP 
  26
The profile of age, sex and co-morbidity differs between the cohorts where the ERCP 
patients tend to be older, to a larger extent of male sex and to have more severe co-
morbidity according to the Charlson index. On the contrary, patients treated with 
laparoscopic CBD exploration are significantly younger, more often women, and tend 
to have less comorbidity. Pancreatitis, which may be either a complication of the biliary 
stone disease or a complication of the procedure, is reported in 0.6% of patients after 
open surgery, in 5.9% after ERCP and in 3.4% after laparoscopic exploration (Table 1). 
 
Both the 30- and 90-day mortality is around 3-fold higher after ERCP than after open 
CBD exploration. Also in this respect laparoscopic CBD exploration differs markedly 
from the other interventions as 90-day mortality is 0 in this cohort.  The proportion that 
has a reintervention within 90 days after ERCP is also significantly, i.e. up to 5-fold 
higher, than in the laparoscopic and open CBD exploration cohorts. 
     
The Kaplan-Meier survival curves (Figure 2) confirm that crude survival is higher after 
laparoscopic common bile duct exploration and then gradually decreases for open 
surgery, surgery and ERCP and is lowest after ERCP alone. 
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 OPEN CBD 
EXPLORATION 
N=54581 
N (%) 
ERCP 
 
N=67078 
N (%) 
LAPAROSCOPIC 
CBD 
EXPLORATION 
N= 2244 
N (%) 
SURGERY AND 
ERCP 
N=2982 
N (%) 
Age, mean (std) 60 (17) 67 (17) 48 (18) 65 (17) 
     
Sex, male 20616 (38) 29281 (44) 577 (26) 1271 (43) 
Comorbidity :     
     Charlson score  0 51922 (95) 58206 (87) 2144 (96) 2720 (91) 
                               1-2 2529 (4.6) 8007 (12) 97 (4.3) 244 (8.1) 
                               3-4   97 (1.8) 555 (0.83) 3 (0.13) 16 (0.53) 
                               ≥5 33 (0.06) 310 (0.46) 0 2 (0.067) 
     
90-day mortality 132 (0.24) 570 (0.85) 0 20 (0.67) 
30-day mortality 56 (0.10) 188 (0.28) 0 10 (0.34) 
     
Pancreatitis 331 (0.60) 3984 (5.9) 76 (3.4) 95 (3.2) 
Septicemia 47 (0.086) 257 (0.38) 1 (0.045) 17 (0.57) 
     
Length of stay, mean (std) 16 (14) 7.2 (10) 4.2 (5.2) 20 (15) 
Readmission within 30 days  9153 (17) 11942 (18) 235 (10) 609 (20) 
New procedure within 90 days 3229 (5.9) 13303 (20) 98 (4.3) 430 (14) 
 
Table 1.  Characteristics and basic data on patients treated for common bile duct stone 
disease 1965-2009. 
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Figure 2. Kaplan-Meier curves illustrating crude survival after treatment of common 
bile duct stones. 
 
4.1.1 Factors Influencing Survival 
Both age and sex influenced survival after treatment of common bile duct stones. The 
influence of age was further increased in the multivariate analysis by interaction with 
co-morbidity (Table 2). Female sex reduced the risk of dying, a difference that 
remained in the multivariate analyses (adjusted HR 0.75 95% CI 0.64-0.87).  
 
Comorbidity, measured using the Charlson comorbidity score, increased the risk of 
death to a high degree and the influence was enhanced in the multivariate analyses 
where a score ≥5 increased the risk of dying 400-fold (adjusted HR 408; 95% CI 127-
1320) due to interaction with age. 
 
Septicemia did not affect the risk of death in the multivariate analyses while 
pancreatitis surprisingly was associated to a significantly lower risk of dying. 
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The length of hospital stay had no impact on the risk of death and neither had a 
readmission. On the contrary the occurrence of a biliary reintervention, either 
endoscopic or transabdominal, within 90 days was associated to a 14-fold increased 
risk of dying (adjusted HR 14; 95% CI 12-17).  
  
The type of procedure seemed to affect 90-day mortality where ERCP had a crude HR 
of 3.6 (95% CI 3.0-4.4) and 2.9 (95% CI 1.98-4.7) if combined with surgery compared 
to open surgery. However, in the multivariate analyses the effect was reduced to a non-
significant trend (HR 1.6; 95% CI 0.86 – 2.8). As survival in the laparoscopic cohort 
was close to complete even at long term follow-up the statistical power was not 
sufficient for Cox regression for this exposure. It is however clear that survival in this 
cohort is many-fold higher than in the other intervention cohorts. 
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 UNIVARIATE ANALYSIS MULTIVARIATE ANALYSIS 
 P Crude HR 95% CI P Adjusted HR 95% CI 
Age ≤51 years   1.0 (reference)  1.0 (reference) 
       52-67 years <0.001 4.6 2.9-7.5 <0.001 6.2 3.6-11 
       68-77 years <0.001 8.1  5.1-13 <0.001 17 9.0-32 
       ≥78 years <0.001 22 14-34 <0.001 77 36-165 
Sex Male  1.0 (reference)  1.0 (reference) 
       Female <0.001 0.59  <0.001 0.75 0.64-0.87 
Comorbidity       
Charlson 0   1.0 (reference)  1.0 (reference) 
               1-2 <0.001 4.9 3.9-5.4 <0.001 16 9.7-26 
               3-4 <0.001 7.2 4.6-11 <0.001 104 38-288 
               ≥5 <0,001 8.2 4.5-15 <0.001 408 127-1320 
Pancreatitis No  1.0 (reference)  1.0 (reference) 
                    Yes 0.004 0.40 0.21-0.75 0.05 0.54 0.29-1.0 
New procedure within 90 days No  1.0 (reference)  1.0 (reference) 
                                                  Yes <0.001 15 13-18 <0.001 14 12-17 
Surgery Open  1.0 (reference)  1.0 (reference) 
              ERCP <0.001 3.6 3.0-4.4 0.15 1.6 0.86-2.8 
              Lap 0.89 0  0.89 0  
              Surg+ ERCP <0.001 2.9 1.8-4.7 0.84 1.4 0.13-5.2 
                    
Table 2. Cox regression model with Hazard ratio and their 95% confidence intervals 
for risk of death within 90 days after treatment of common bile duct stone disease with 
respect to some potential risk factors. 
 
4.2 PAPER II 
 
The final cohort of patients having undergone ERCP, for diagnostics or therapy of non-
malignant disease, included 27 708 patients contributing to a total of 235 518 person-
years of follow-up. Table 3 shows the steps of selection of patients from the total cohort 
including all ERCP procedures to the eligible final benign disease ERCP cohort. The 
sum of the ES and non-ES groups is larger than the all ERCP group, because 2 141 
patients had an ERCP without ES before a subsequent ERCP with ES. Of these, 306 
did not have a diagnosis of malignancy at the time of the first nor second index 
procedures and neither within two years thereafter, and were thus counted in both 
subgroups. 
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 ALL 
ERCP 
 ES ERCP WITHOUT 
ES 
Total 54 135 30 431 25 846 
Cancer date before entry 10 085 5 734 4 764 
Error registration 3 192 3 000  329 
Follow-up less than two 
years 
13 150 9 068 5 368 
Eligible 27 708 12 629 15 385  
Table 3. Size of cohorts of patients having undergone Endoscopic Retrograde 
CholangioPancreaticography (ERCP) with or without Endoscopic Sphincterotomy 
(ES). 
 
The risk of developing malignancy in the bile ducts, liver or pancreas, excluding 
gallbladder malignancy, was 3-fold increased in the all ERCP cohort compared to the 
general population (SIR 3.0; 95% CI 2.6-3.4). Likewise it was 3-fold increased in the 
ES subgroup (SIR 3.0; 95% CI 2.3 – 3.8) and in the non-ES subgroup (SIR 2.9; 95% CI 
2.4 – 3.3).  
 
In the all ERCP cohort the risk of malignancy of the bile ducts, liver or pancreas 
decreased gradually by increasing duration of follow-up. The relative risk (SIR) was 
3.6, with 95% CI 3.0 – 4.3, in the period between two and four years after the index 
ERCP and the point estimates for the relative risks between five and nine years, and ten 
years and more, after the index ERCP, were 2.9 and 2.2 respectively (Table 4). The 
analyses stratified by ES show a similar pattern, with decreasing point estimates for 
relative risks with longer follow-up. There was no significant difference between the 
ES and non-ES subgroups in the relative risk estimates by duration (Table 4). 
YEARS 
AFTER 
PROCEDURE 
ALL ERCP                             
N= 27 708 
 E          O             SIR 
                           (95% CI) 
 ES 
N= 12 629 
E           O            SIR 
                          (95% CI)   
ERCP WITHOUT ES 
N= 15 385 
E           O             SIR 
                         (95% CI) 
2-4 32 113 3.6            
(3.0-4.3) 
13 40 3.1       
(2.2-4.2) 
19 72 3.8       
(3.0-4.8) 
5-9 31 88 2.9       
    (2.3-3.5) 
8 25 3.0      
(1.9-4.4) 
22 56 2.5       
(1.9-3.3) 
> 10 16 35 2.2       
(1.5-3.0) 
1 1 0.9     
(0.02-5.0) 
15 28 1.9       
(1.3-2.8) 
 
 Table 4.  Expected (E) and Observed (O) cases and Standardized Incidence Ratios 
(SIRs) with 95 % Confidence Intervals (CI) for developing carcinoma in the liver, 
pancreas or biliary tract after ERCP by duration. 
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The risk of malignancy in the bile ducts, liver and pancreas two years or more after 
ERCP was significantly lower among patients who ever had had a cholecystectomy 
(SIR 2.3; 95% CI 1.8 – 2.9 in the all ERCP-group) compared to patients who had not 
(SIR 3.4; 95% CI 3.0 – 4.0). This finding was not at all affected by ES exposure. 
 
4.3 PAPER III 
During the time period a total of 5750 ERCP procedures were performed in Stockholm 
County in patients without a diagnosis of malignancy in the liver, pancreas or bile ducts 
and 90 patients died within 90 days, giving a total mortality of 1.6%. In seven cases the 
cause of death could be directly related to the procedure (one case of hemorrhage, two 
of pancreatitis and four perforations), giving a procedure-caused mortality of 0.1%. 
Characteristics of patients who had undergone ERCP for non-malignant disease are 
shown in Table 5 together with basic information on their procedures. 
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Table 5. Characteristics of patients having had ERCP on benign indication by death 
within 90 days or not and data on their procedures.  
 
4.3.1 Age and sex 
The patients who died within 90 days were older (mean 76 years) than controls (65 
years) (Table 5). After categorization by the median age 73, univariate analysis gave a 
four-fold Odds Ratio (OR 4.0 CI 2.2-7.0) for age ≥73. This was further enhanced in the 
multivariate analyses due to interaction with comorbidity to 8.7 (CI 3.6-21), estimating 
the odds for death in those with a comorbidity score <2 and age ≥73 (Table 6). There 
was no significant difference between sexes. 
 CASES N=90 
(%) 
CONTROLS N=146 
(%) 
 
Date before 1997 44 (49) 52 (36) P=0.04 
Low volume (≤200/y) 37 (41) 73 (50) P=0.18 
Mean age (st dev) 76 (14) 65 (17) P<0.001 
Sex (female %) 50 (56) 86 (59) P=0.61 
Charlson comorbidity ≥2 41 (46) 23 (16) P<0.001 
Previous  cholecystectomy 12 (13) 50 (34) P<0.001 
Indication    
     Gallstone 46 (51) 86 (59) P=0.24 
     Complicated gallstone  13 (28) 17 (19) P=0.27 
     Acute pancreatitis 20 (22) 20 (14) P=0.083 
     Chronic pancreatitis 7 (8) 23 (16) P=0.074 
     Other 19 (21) 28 (19) P=0.86 
Complex procedure 49 (54) 57 (39) P=0.008 
Contrast in pancreatic duct 32 (27) 59 (42) P=0.53 
Sphincterotomy 36 (40) 85 (58) P=0.007 
Inadequate drainage 19 (21) 21 (14) P=0.19 
Complication 35 (39) 31 (21) P=0.003 
LOS≥ 3 days 50 (56) 64 (44) P=0.08 
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4.3.2 Comorbidity 
Charlson comorbidity index ≥2 was a strong risk factor for death, giving a four-fold 
increase of the Odds Ratio (OR 4.5; CI 2.4-8.2) and due to interaction with age the OR 
was further increased in the multivariate analysis (OR 9.2; CI 2.9-29 for those under the 
age of 73). 
 
4.3.3 Indications  
A history of cholecystectomy was more common among the 90 day survivors (OR 
0.41; CI 0.18-0.94), but we found no difference when comparing indications for the 
procedure in terms of simple gallstone disease or a more severe disease with cholangitis 
or septicemia (OR 1.7; CI 0.8-3.4). When chronic pancreatitis was the indication for 
ERCP the point estimate suggested a lower risk of mortality but it was not statistically 
significant (OR 0.4 CI 0.14-1.1). 
 
4.3.4 Procedure-related factors  
Among those who died, a procedure classified as complex was more common (OR 2.0; 
CI: 1.1-3.8). Injection of contrast medium into the pancreatic duct was not associated 
with post ERCP death (OR 0.7 95% CI 0.4-1.5).  
 
Complications were more common among patients who died, even though the 
complication per se led to death in only a few cases. Procedure-related complications 
increased the risk of death within 90 days approximately four-fold (OR 3.7; CI: 1.7-8.1)  
 
Performance of an endoscopic sphincterotomy was more common among controls and 
thus associated with a decreased post-ERCP mortality (adjusted OR 0.36; 95% CI 0.18-
0.69).  
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 UNIVARIATE ANALYSIS 
P             OR         95% CI 
MULTIVARIATE 
ANALYSIS 
P             OR          95% CI 
Age<73 years  1.0   (reference)  1.0 (reference) 
Age≥73 years <0.001 4.0 2.2-7.0 <0.001 8.7 3.6-21 
Gender (male)  1.0   (reference)  1.0 (reference) 
Gender (female) 0.61 0.87 0.5-1.5 0.73 0.89 0.46-1.7 
Charlson comorbidity<2  1.0   (reference)  1.0 (reference) 
Charlson comorbidity≥2 <0.001 4.5 2.4-8.2 <0.001 9.2 2.9-29 
Previous cholecystectomy       
                no  1.0   (reference)  1.0 (reference) 
                yes 0.001 0.30 0.15-0.60 0.035 0.41 0.18-0.94 
Complex procedure       
                no  1.0   (reference)  1.0 (reference) 
                yes 0.009 2.1 1.2-3.7 0.036 2.0 1.1-3.8 
Sphincterotomy       
                no  1.0   (reference)  1.0 (reference) 
                yes 0.007 0.5 0.3-0.8 0.002 0.36 0.18-0.69 
Drainage       
               good  1.0   (reference)  1.0 (reference) 
               not good 0.20 0.64 0.32-1.3 0.85 0.92 0.38-2.2 
Complication       
              no  1.0  (reference)  1.0 (reference) 
              yes 0.004 2.4 1.3-4.2 0.001 3.7 1.7-8.1 
 
Table 6. Risk of death after ERCP with respect to some potential risk factors.  
 
4.4 PAPER IV 
 
Laparoscopic transcystic common bile duct exploration was commenced in 155 
patients and was completed in 132 (85 %), without remaining CBD stones on the 
second cholangiogram. Hospital stay and mean operating time were significantly longer 
among patients where stone clearance failed. Stone size and common bile duct diameter 
were both significantly larger in patients where stone clearance failed, compared to 
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those where it was successful, using conventional significance testing. There were no 
significant differences between patients with successful and failed stone clearance 
regarding age, sex, procedure priority, number of stones and intrahepatic stone location. 
 
In 123 out of 132 stone free LTCE patients one or more stones were extracted. In the 
remaining nine, no stone could be found at cholangioscopy, or in the second 
cholangiogram, which could either be because of false positive first cholangiograms or 
because of stone clearance between the cholangiogram and cholangioscopy, perhaps 
due to flushing of saline through the bile duct at the onset of cholangioscopy. In 24% of 
the patients an intrahepatic cholangioscopy was performed.  
 
There were eight postoperative complications among the LTCE patients. Three patients 
had haemorrhage requiring transfusion, two had pneumonia, one had pancreatitis, one 
had pulmonary embolism and finally one had bile leakage needing percutaneous 
drainage but no further intervention. One of the patients who had haemorrhage 
requiring transfusion was reoperated because of an infection in the hematoma. 
Otherwise no reoperations were needed. There was no mortality during the hospital 
stay or at the follow-up six week postoperatively. Follow-up at six weeks was 
completed in 91% of the patients and all of them were clinically well, but one had 
elevated liver enzymes. A postoperative normal ERC was performed and an ES was 
made as a precaution, although no retained CBD stone was found. An additional patient 
had a postoperative ERC done due to a history of repeated biliary colic two years after 
surgery. The ERC showed a CBD stone that was removed after ES. Apart from that no 
patient was shown to have retained or recurrent stones. 
 
In the logistic regression analyses there were no significant effects of age, sex or 
number of stones on the risk of failure in stone clearance (Table 7).  
 
Univariately, there was an almost 11-fold significant increase in the risk of failure in 
stone clearance among patients with a common bile duct diameter of >6 mm compared 
with those with a diameter of 6 mm (OR: 10.62; 95% CI: 1.39 – 81.48). However in 
the multivariate analyses this effect decreased markedly and was no longer statistically 
significant (OR: 6.90; 95% CI: 0.87 – 54.61). This difference was due to confounding 
from the effect of stone size (Table 7). 
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 UNIVARIATE  
OR       (95% CI) 
 MULTIVARIATE 
OR     (95% CI) 
      
Age, years      
       <55 1.00 (reference)  1.00 (reference) 
      >=55 1.42 (0.56 - 3.58)  1.33 (0.48 - 3.70)  
      
Gender      
     Female 1.00 (reference)  1.00 (reference) 
     Male 1.78 (0.71 - 4.48)  1.57 (0.58 - 4.24) 
      
Bile duct diameter, mm      
     <= 6  1.00 (reference)  1.00 (reference) 
      >6  10.62 (1.39 - 81.48)  6.90 (0.87 - 54.61) 
      
Stone size, mm      
      <=5  1.00 (reference)  1.00 (reference) 
       >5  3.95 (1.50 - 10.40)  3.13 (1.15 - 8.56) 
      
Number of stones      
      <3  1.00 (reference)  1.00 (reference) 
      >=3  1.65 (0.66 - 4.14)  1.43 (0.52 - 3.92) 
 
Table 7.  Risk of failure in stone clearance in laparoscopic transcystic common bile 
duct exploration with regard to some potential risk factors. 
 
Multivariately there was a significant 3-fold increase in the risk of failure in stone 
clearance among patients with a mean stone size of >5 mm compared to patients with 
5 mm (OR: 3.13; 95% CI: 1.15 – 8.56). Univariate data did not differ markedly from 
the multivariate result, indicating none or limited confounding effects in the analysis of 
stone size (Table 7).   
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5 DISCUSSION 
During the last decades treatment of common bile duct stone disease has changed. 
Open surgery has gradually been replaced by endoscopic surgery and in the later years 
also by laparoscopic surgery to some extent. The central issue in this thesis was to try to 
clarify how common bile duct stone disease may be treated in these times of changes. 
Our hypothesis when starting the work was that laparoscopic treatment would be 
superior to other methods of treatment, based on the reports on short- and long-term 
side-effects of ERCP, especially ES. Reports on short-term side-effects included 
pancreatitis, perforations, hemorrhage and cholangitis causing a substantial morbidity 
and mortality [213] while long-term side-effects included reports on an elevated risk of 
cholangiocarcinoma after endoscopic sphincterotomy. The under-lying mechanism 
could be that the interruption of the sphincter would cause an over-growth of bacteria 
with longstanding carcinogenic inflammation in the bile ducts that normally are sterile 
[178, 181]. This could be alarming since endoscopic surgery in recent years has 
become a routine procedure even in young and healthy individuals and not only in the 
old and fragile as in the early days. 
 
5.1 HOW HAVE COMMON BILE DUCT STONES BEEN TREATED IN 
SWEDEN? 
To address this question we conducted a population-based retrospective cohort study 
(study I) which comprised all patients in Sweden 1965-2009 with an in-patient 
procedure code of open or laparoscopic exploration of the common bile duct or ERCP 
but without a diagnosis of malignancy in the bile ducts, liver or pancreas by the time of 
the procedure or within 90 days after it. In the majority of these patients the indication 
for the procedure would have been common bile duct stone disease. The cohort was 
divided into four subgroups: open surgery, ERCP, laparoscopic surgery and finally 
open and/or laparoscopic surgery combined with ERCP.  
 
The study reflects treatment in a vast majority of the Swedish population and the 
registries from which the data are collected have been validated as mentioned in the 
methods-section giving an essentially complete follow-up. The Hospital Discharge 
Registry was established in 1964 and included all Swedish Hospitals from 1987 and 
onwards. It has been validated with a 94% agreement for surgical procedure codes 
[214] and 87-95% for discharge diagnoses [215, 216], however the codes and 
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diagnoses in this study have not been validated specifically. Misclassification could 
introduce information bias, although it seems unlikely that misclassification would 
differ between the subgroups or regarding outcome status, meaning that introduced bias 
would be non-differential and thereby diluting the strength of true associations. It was 
however not possible to analyze the procedures on an intention to treat basis and 
converted laparoscopic procedures are registered in the cohorts of open or combined 
surgery. This could imply an over-representation of severe cases in these cohorts and a 
corresponding under-representation in the laparoscopic cohort. 
 
In the beginning of the studied time period open surgery was the only available method 
for treatment of common bile duct stone disease but from the early 1990s and on 
endoscopic treatment has become predominant. Laparoscopic treatment was introduced 
in the early 1990s and has been used in a small proportion of cases.  
 
5.1.1 What Risk Factors for Death Could Be Identified? 
Age and comorbidity were identified as main risk factors for death. There were 
differences between the subgroups in the way that patients treated with ERCP were 
older and had a more severe comorbidity than those treated with open surgery, not 
surprisingly, since ERCP was used in patients considered too old and frail to have open 
surgery, at least in the beginning of the time period. Patients treated with laparoscopic 
surgery were younger and healthier than the others and also more often of female sex, a 
circumstance connected to a significant decreased risk of dying after surgery in this 
study. 
 
A new biliary procedure within 90 days, probably implying that clearance of the bile 
duct was not achieved at the first attempt, was a significant risk factor for death while a 
discharge code of acute pancreatitis was associated with a better survival. Both a redo 
procedure and a diagnosis of pancreatitis were more common among ERCP-patients. 
 
5.1.2 Did Mortality Differ? 
The crude 90-day mortality was significantly higher after ERCP compared to after open 
surgery but after adjusting for age and comorbidity this result was reduced to a trend. 
The results after laparoscopic surgery were excellent with no 90-day mortality at all 
recorded, but that must be interpreted with caution, since it to some extent could be 
explained by a case-selection described above. The laparoscopy subgroup consisted of 
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members of lower age and comorbidity and the fact that the procedure could be 
completed laparoscopically could imply a less severe disease. 
 
 
5.2 IS THE RISK OF DEVELOPMENT OF MALIGNANCY ELEVATED 
AFTER ENDOSCOPIC SPHINCTEROTOMY? 
A cohort study (study II) was designed to evaluate whether the longstanding 
inflammation caused by ascending infection after interruption of the sphincter of Oddi 
would lead to an increased risk of cholangiocarcinoma. The population-based cohort 
comprised all individuals in Sweden with a discharge code of an in-patient ERCP with 
or without ES and without a diagnosis of malignancy in the bile ducts, liver or pancreas 
at the time of the procedure or within two years after it up to the year 2003.  
 
Since cholangiocarcinoma is a rare disease and there is a risk of missclassification 
between extrahepatic cholangiocarcinoma and pancreatic cancer as well as intrahepatic 
cholangiocarcinoma and liver cancer both cholangiocarcinoma alone and all three 
tumours were analyzed. 
 
We found a three-fold elevated risk of malignancy in the whole cohort, i e disregarding 
if an ES had been performed or not, compared to the general population. The risk 
declined with time. These results imply that the elevated risk of malignancy was not a 
result of the ES per se but rather of some other exposure common for the entire cohort, 
the most likely would be gallstone disease, a notion that to some extent could support 
the finding that a previous cholecystectomy in this study was shown to be associated to 
a lower risk of malignancy. 
 
5.3 DOES ENDOSCOPIC SPHINCTEROTOMY INCREASE SHORT-TERM 
COMPLICATIONS AFTER ERCP? 
A case-control study (study III) was designed to evaluate short-term outcome after 
ERCP, especially mortality, and to study risk factors for death. The main hypothesis 
was that a potentially dangerous procedure like sphincterotomy would be such a risk 
factor. It was performed on a subgroup of patients included in paper II. Cases were 
defined as all individuals who had had an ERCP in Stockholm County during 1990-
2003 and who died within 90 days of the procedure and as controls served a random 
sample from the same subgroup. The population-based design was chosen to reduce the 
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risk of bias in case and control selection. Risk factors for death were discerned from the 
medical records, to reduce information bias the parts of the medical records regarding 
the ERCP procedure were coded and reviewed blinded for case and control status.  
 
The all cause mortality was 1.6% but only seven deaths (0.1%) were directly 
procedure-related. Advanced age and severe co-morbidity were identified as the main 
risk factors for death. A complex procedure, here defined as the presence of a duodenal 
diverticulum, multiple attempts of cannulation, difficult position of the papilla or the 
performance of a pre-cut sphincterotomy, was also identified as a risk factor as well as 
the occurrence of a post-procedural complication. A previous cholecystectomy served 
protective for death, possibly by reducing the severity of the common bile duct stone 
disease by the time of the ERCP, even though that could not be confirmed in the 
medical records.  
 
In contrast to our prior hypothesis the performance of a sphincterotomy could not be 
identified as a risk factor for death, on the contrary it reduced the risk, a condition that 
remained significant in the multivariate analyses (OR 0.36, 95% CI 0.18-0.69), thereby 
not explained by the factors we adjusted for (age, comorbidity, date of procedure, 
previous cholecystectomy, complex procedure or the occurrence of a complication). A 
possible explanation could be that a completed sphincterotomy could reduce the risk of 
cholangitis by facilitating a good drainage from the bile ducts.  
 
5.4 WHAT IS THE SHORT-TERM OUTCOME OF LAPAROSCOPIC 
TRANSCYSTIC COMMON BILE DUCT EXPLORATION AND WHEN 
DOES IT FAIL?  
To address these issues we conducted a study of patients in whom LTCE were 
attempted at S: t Göran’s Hospital during the years 1994- 2002. The study included all 
patients, thereby reducing the risk of selection bias. Data had been prospectively 
collected in a data-base and analyses showed that stone clearance was achieved in 85%.  
There was no recorded 30-day mortality (in agreement with the findings in study I), a 
low mortality and a short postoperative hospital stay. As risk factors for mortality stone 
size >5 mm could be identified and probably also a wide bile duct (>6mm). 
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5.5 GENERAL DISCUSSION 
Our main hypothesis, that laparoscopic common bile duct exploration would be 
superior to other methods of treatment of common bile duct stones, could not be proven 
by this thesis. Indeed, laparoscopic treatment was safe and no 90-day mortality was 
reported in Sweden in cases where it could be fulfilled, yet it was applied in a minority 
of patients. We could identify large stones as a risk factor for failure in laparoscopic 
transcystic exploration, in laparoscopic choledochotomy stone size is not regarded as an 
obstacle [195, 200] and the reason why laparoscopic treatment was refrained from in a 
majority of cases is not clear. We can only speculate- perhaps the methods are regarded 
as complicated or the instruments fragile or difficult to handle. Laparoscopic treatment 
was chosen mainly in young and otherwise healthy subjects and the complexity of the 
bile duct stone disease could have had impact, patients with less severe disease could 
have been selected to laparoscopy.  When laparoscopic treatment was chosen stone 
clearance could be achieved in a majority of cases, but not in all, and there is a need for 
alternative methods.   
 
The by far most common way to treat gallstones and common bile duct stones in later 
years is by a combination of laparoscopic cholecystectomy and endoscopic treatment of 
the bile duct stones. Since ERCP and especially ES have been reported with a 
substantial morbidity and mortality [177-180, 217] and also with an increased risk of 
malignancy in the long run [181] this has been a matter of some concern. Our study 
showed an increased risk of development of a malignancy in all patients having had an 
ERCP on benign indication but the risk was elevated regardless of if an ES was 
performed or not and diminished with time thereby contradicting that the ES per se 
would be a causal factor. The 90-day mortality after ERCP was substantial in our study 
and as risk factors advanced age and severe comorbidity could be identified while the 
performance of an ES reduced the risk of dying. Our studies do not support the reports 
that the performance of a sphincterotomy would be a causal factor of short- or long-
term mortality and morbidity after ERCP. 
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6 CONCLUSIONS 
Treatment of patients with gallbladder stones and simultaneous stones in the common 
bile duct has changed. Earlier all patients had open surgery while in the recent years a 
combination of laparoscopic cholecystectomy and ERCP is predominant even though 
open surgery and laparoscopic treatment are also used. 
 
The mortality after ERCP in benign disease was higher than after open surgery but 
when adjusting for age and comorbidity the difference was reduced to an insignificant 
trend. 
 
Laparoscopic treatment of common bile duct stones was safe but could not be used in 
all patients. 
 
The risk of malignancy in the bile ducts, liver and pancreas after ERCP on benign 
indication was elevated in all patients regardless of if an ES was performed or not and 
diminished with time contradicting that ES would be a causal factor. 
 
The main risk factors for death after ERCP in benign disease were old age and 
advanced co-morbidity, while a procedure considered complex or causing a 
complication contributed to the risk. The performance of an ES reduced the risk of 
dying within 90 days after the procedure and the risk was also reduced in patients 
having had a previous cholecystectomy. 
 
Stone size > 5 mm was a risk factor for failure in laparoscopic transcystic exploration 
of the common bile duct. 
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7 POPULÄRVETENSKAPLIG SAMMANFATTNING 
 
Gallstensjukdom är vanlig och årligen utförs drygt 10 000 galloperationer i Sverige. 
Mellan 5-15 % av patienterna har även sten i de djupa gallvägarna (koledokussten) vid 
operationen. Dessa patienter behandlades under större delen av 1900-talet i en seans 
med öppen kirurgi. Under 1970-talet kom endoskopiska metoder där man med ett 
flexibelt endoskop via munnen kunde genomföra kontraströntgen och avlägsna stenar i 
gallvägarna efter klyvning av sfinkter Oddi, ringmuskeln runt gallvägens mynning i 
tolvfingertarmen (endoskopisk retrograd cholangiopankreatografi, ERCP, med 
endoskopisk sfinkterotomi). Sfinkterotomi visade sig vara förenad med risk för 
allvarliga komplikationer och reserverades först för patienter som ansågs vara för 
gamla eller sjuka för att klara öppen kirurgi. Farhågor framfördes också att delningen 
av sfinktern skulle kunna ge en kronisk infektion i gallvägarna genom tillträde för 
bakterier från tolvfingertarmen och att denna kroniska infektion/inflammation skulle ge 
en ökad risk för cancer på lång sikt.   
Senare, under 1990-talet, introducerades galloperation via titthål (laparoskopisk 
kolecystektomi) och denna metod blev snart helt dominerande. Behandlingen av 
samtidig sten i gallgången blev mer varierande och öppen kirurgi, kombination av 
endoskopisk och laparoskopisk teknik i en eller två seanser har använts olika på olika 
sjukhus sannolikt beroende på lokal behandlingstradition.  
 
Syftet med denna avhandling var att kartlägga hur patienter med samtidig sten i 
gallgång och gallblåsa behandlats i Sverige under denna period av förändringar (1965-
2009), att beräkna dödlighet efter olika behandlingsmetoder och att identifiera 
riskfaktorer för död. Svängningen i behandlingstradition har inneburit att även unga 
patienter genomgår ERCP och sfinkterotomi vilket skulle kunna vara alarmerande om 
cancerrisken ökar på lång sikt, detta ville vi undersöka närmare. En ökad användning 
av ett potentiellt farligt ingrepp som sfinkterotomi skulle kunna vara farligt även på kort 
sikt varför vi ville identifiera riskfaktorer för död efter ERCP, och särskilt studera om 
sfinkterotomi var en sådan riskfaktor. På S: t Görans sjukhus har sedan 1994 den 
dominerande tekniken varit att behandla samtidig sten i gallblåsa och gallgång i en 
seans, där gallblåsan och stenarna i gallgången avlägsnas med titthålskirurgi och vi ville 
utforska resultatet samt om metoden har några begränsningar. 
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Fyra delarbeten ingår: 
 
1. Behandling av koledokussten i Sverige 1965-2009, en landsomfattande 
populationsbaserad studie.  
 
2. Endoskopisk sfinkterotomi och risk för malignitet i gallvägar, lever och 
bukspottskörtel.  
 
3. Endoskopisk sfinkterotomi kan minska risken för död efter ERCP- en 
populationsbaserad fall-kontroll studie. 
 
4. Stenfrihet och riskfaktorer för misslyckande att åstadkomma detta vid 
titthålsoperation av gallsten i gallvägarna. 
 
Delarbete 1 omfattar alla personer i Sverige som vårdats inneliggande för en operation 
av sten i gallvägarna eller ERCP under åren 1965-2009. ERCP görs också vid 
cancersjukdom i gallvägar, lever och bukspottskörtel och efter samkörning med 
cancerregistret kunde dessa individer identifieras och exkluderas ur studien. Totalt 
110 119 personer identifierades och dessa hade genomgått totalt 126 889 ingrepp. 
Dödligheten efter olika ingrepp skiljde sig, efter öppen operation dog 0,24 %, efter 
ERCP 0,90 % och efter titthålskirurgi dog ingen person inom 90 dagar. Vid närmare 
analys visade sig skillnaden i dödlighet efter öppen kirurgi och ERCP förklaras av att 
patienterna som genomgått ERCP var äldre och sjukare. 
 
Delarbete 2 omfattar alla personer i Sverige som genomgått ERCP under åren 1965- 
2003 utan att ha en diagnos av malignitet i gallvägar, lever eller bukspottskörtel vid 
ingreppet eller inom två år därefter. I cancerregistret identifierades de som senare 
utvecklade malignitet. Det visade sig att risken att utveckla cancer i gallvägar, lever 
eller bukspottskörtel var större hos alla dessa patienter jämfört med 
normalbefolkningen men att risken minskade med ökande uppföljningstid och inte 
påverkades om sfinkter Oddi delades eller inte. 
 
Delarbete 3 omfattar en del av personerna i delarbete 2, de som genomgått ERCP i 
Stockholms län 1990-2003. De som dött inom 90 dagar efter ingreppet jämfördes med 
slumpvis utvalda kontroller bland dem som inte dött. Som riskfaktorer för att dö kunde 
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hög ålder, sjuklighet, ett komplicerat ingrepp och att en komplikation tillstötte 
identifieras medan om personen ifråga tidigare genomgått galloperation eller om 
klyvning av sfinkter Oddi utfördes vid det aktuella ingreppet minskade risken för död. 
 
Delarbete 4 omfattar alla patienter som opererats på S: t Görans sjukhus under perioden 
1994-2002 där man försökt ta bort stenar i gallgången med en typ av titthålskirurgi. 
Den metod som användes var transcystisk exploration där gången mellan gallblåsan 
och djupa gallvägen öppnas och vidgas. Stenarna i gallgången fångas med hjälp av ett 
tunt endoskop som förs in denna väg och de kan sedan avlägsnas en efter en. Av de 155 
patienter där man inlett denna operation kunde stenfrihet uppnås hos 85 % och som 
riskfaktor för misslyckande identifierades stenstorlek, hos patienter med 
koledokusstenar större än 5 mm ökade risken för misslyckande trefaldigt. 
 
Slutsatser: Dödlighet efter behandling av choledochussten skiljer sig mellan olika 
behandlingsmetoder. Dödligheten är högre efter ERCP än efter öppen kirurgi men detta 
förklaras av att patienterna som genomgår ERCP är äldre och sjukare. Dödligheten 
efter laparoskopisk gallvägskirurgi är noll inom 90 dagar, dessa patienter är dock yngre, 
friskare och har möjligen en mindre avancerad gallstenssjukdom. 
Risken för att utveckla cancer i gallvägar, lever och bukspottskörtel är högre hos alla 
patienter som genomgått ERCP än hos normalbefolkningen. Risken avtar med ökande 
uppföljningstid och påverkas inte av om sfinkter Oddi klyvs eller inte, utan orsakas av 
någon annan faktor som dessa patienter har gemensamt, sannolikt gallstenssjukdom. 
Hög ålder, sjuklighet, svårt och komplext ingrepp ökar risken för död efter ERCP 
liksom om en komplikation uppträder efter ingreppet. Den potentiellt farliga 
klyvningen av sfinkter Oddi minskar däremot risken sannolikt p.g.a av att dränaget från 
gallgången förbättras och risken för uppåtstigande infektion i gallvägarna minskar.  
Laparoskopisk behandling av sten i gallvägarna genom en transcystisk exploration är 
en metod som ger få komplikationer och kort vårdtid när den är genomförbar. Den kan 
dock inte användas hos alla patienter och i denna studie kunde stenstorlek över 5 mm 
identifieras som en riskfaktor för misslyckande.  
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